Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Avista Sells Accuratus Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Avista Sells Accuratus Facility

Strategic exit allows Avista to focus on core pharmaceutical contract services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Avista Pharma Solutions, Inc. sold its facility in Eagan, MN to Microbiology Research Associates, a portfolio company of Thompson Street Capital Partners. The Eagan facility, which operates as Accuratus Lab Services (Accuratus), provides testing services for antimicrobial products that are regulated by the Environmental Protection Agency (EPA). The sale is a strategic exit for Ampersand Capital Partners, the private equity owner of Avista Pharma, and allows Avista Pharma to focus on its core market in pharmaceutical contract services.
 
“Our Accuratus site in Eagan has been a high-performing site for Avista Pharma, and we want to thank the leadership team and employees for their dedication to the business,” said Mr. Patrick Walsh, chief executive officer of Avista Pharma.
 
Avista Pharma was formed through the strategic combination of three businesses serving the pharmaceutical, animal health and medical device industries. Avista Pharma is a contract testing, development and manufacturing organization with locations in Durham, NC; Longmont, CO and Agawam, MA.
 
Avista Pharma was represented by investment banking firm Fairmount Partners based in West Conshohocken, PA.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters